Filing Details

Accession Number:
0001596783-23-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-03 19:00:37
Reporting Period:
2023-05-01
Accepted Time:
2023-05-03 19:00:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1939253 Manja Boerman C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
Pres. Biomodalities Division No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-01 1,446 $49.86 14,414 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
  2. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $49.71 to $50.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes restricted stock units.